Arturo Md Molina sold $1.1M of Protagonist Therapeutics (PTGX)

Executed Jun 9 2025, disclosed Jun 11 2025, 2 days later.

Value, as filed

$1.1M

20,000 sh across 2 lots

Executed

Jun 9 2025

the trade date, as filed

Disclosed

Jun 11 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Arturo Md Molina Chief Medical Officer profile →

Arturo Md Molina (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.9M of PTGX (23,151 sh across 3 lots, as filed), executed Jan 23.

The name

PTGX

Protagonist Therapeutics, Inc. PTGX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Arturo Md Molina in PTGX

PTGXSALE Protagonist Therapeutics, Inc. $1.6M
15,000 sh × $104.79
Exec Mar 26
Filed Mar 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.9M
23,151 sh across 3 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $785K
9,514 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $230K
2,712 sh × $84.77
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.7M
30,514 sh × $55.74
Exec Mar 13 2025
Filed Mar 14 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $119K
as filed
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.4M
31,529 sh across 3 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET